Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand disease

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH08-03-0187
Issue:2008: 100/2 (Aug) pp. 173-364
Pages:211-216

Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand disease

Elsa Lanke1, Ann-Charlotte Kristoffersson2, Malou Philips3, Lars Holmberg2, Stefan Lethagen1,4
1Department for Coagulation Disorders, University Hospital, Malmö, Sweden; 2Department of Pediatrics, Lund University, Sweden; 3Department of Clinical Biochemistry, Copenhagen University Hospital (Rigshospitalet), Denmark; 4Center for Haemostasis and Thrombosis, Copenhagen University Hospital (Rigshospitalet), Denmark

Summary

vonWillebrand factor (VWF) is a plasma protein that consists of a series of multimers of which the high-molecular-weight VWF multimers are the most potent in platelet adhesion and aggregation. The propeptide of theVWF (VWFpp) is known to be essential in the process of multimer assembly. Genetic studies were performed in a patient with a phenotype of vonWillebrand disease (VWD) characterized by very low plasma factorVIII and VWF levels and a VWF consisting of only a dimeric band and total absence of all multimers in plasma.The patient was found to be homozygous for the novel C570S mutation, caused by a 1709G>C transition in exon 14 of theVWF gene coding for the propeptide.Three asymptomatic relatives were found to be heterozygous. In-vitro mutagenesis and expression in COS-7 cells confirmed the detrimental effect of the mutation on VWF multimerization. Our findings show that the C570S mutation in the VWFpp abolishes multimerization of VWF.The mutation probably disrupts the normal configuration of the VWFpp, which is essential for correct orientation of the protomers and ultimately multimerization.The mutant amino acid is located in a region that is highly conserved across several species which underlines its critical role.This variant constitutes a distinct subtype of recessive 2A VWD with the exclusive presence of the dimeric form of VWF in plasma.

Keywords

coagulation, von Willebrand disease, multimerization, COS-7 cell transfection, propeptide

DOI

http://dx.doi.org/10.1160/TH08-03-0187

You may also be interested in...

1.

R. B. Zotz

Hämostaseologie 2008 28 3: 120-129

2.

Marie-Christine Alessi, Irène Juhan-Vague

Thrombosis and Haemostasis 2008 99 6: 995-1000

http://dx.doi.org/10.1160/TH07-11-0682

3.

Helene F. S. Negaard1,4, Per Ole Iversen1,4, Bjørn Østenstad2, Nina Iversen3, Pål A. Holme5, Per Morten Sandset1,4

Thrombosis and Haemostasis 2008 99 6: 1040-1048

http://dx.doi.org/10.1160/TH07-09-0541



Articles

You've 497 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...